BSE announces demat auction for settlement number 741 covering 156 scrips with specified quantities for delivery shortfall resolution.
Impact
Medium
Severity
Medium
Justification
Routine demat auction affecting 156 scrips with varying quantities. While operationally significant for participants with delivery shortfalls, it represents standard settlement mechanism rather than market-wide regulatory change.
13,33,332 equity shares of Vivo Bio tech Ltd. (Scrip Code 511509) issued at Rs. 45/- on preferential basis to Non-Promoters will be listed and permitted to trade on BSE from October 13, 2025.
Impact
Low
Severity
Low
Justification
Routine listing of preferential allotment shares from warrant conversion. Limited market impact due to small issue size and lock-in period.
13,33,332 equity shares of Vivo Bio Tech Ltd. (Scrip Code 511509) issued on preferential basis pursuant to warrant conversion will be listed and permitted to trade from October 13, 2025.
Impact
Low
Severity
Low
Justification
Routine listing of preferential shares from warrant conversion with minimal market impact for a single company
BSE announces listing of 4,48,889 new equity shares of Vivo Bio Tech Ltd issued to promoters through preferential allotment via warrant conversion, effective August 8, 2025.
Impact
Low
Severity
Low
Justification
Routine listing of new shares from warrant conversion with limited market impact due to promoter lock-in until 2027